ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1396 National Cancer Institute Html en Levels of Evidence for Adult and Pediatric Cancer Treatment Studies (PDQ®)–Health Professional Version Information about how to weigh the strength of the evidence obtained in different kinds of cancer treatment studies.
study allocations0.55994
stronger conclusions0.590358
randomized studies0.798135
strength0.75642
evidence0.657795
study allocation0.562189
clinical trials0.717908
randomized study designs0.766704
small systematic errors0.589877
case-control studies0.668928
PDQ editorial boards0.679562
randomized trial0.636458
individual studies0.60263
response rate0.616842
case-only series0.70041
study design0.888134
observational study designs0.736094
PDQ Adult Treatment0.665736
nonconsecutive cases0.672159
PDQ Adult Cancer0.655778
therapeutic strategy0.618175
tumor response rate0.613151
consecutive series0.605201
Treatment Editorial Board0.756511
explicit prospective hypotheses0.587622
internal-control study subjects0.746476
internal comparison group0.725592
patient selection0.600103
different cut points0.60745
nonblinded randomized study0.746604
study designs0.92108
case series0.614267
clinical trial—to case0.64839
study arms0.543205
PDQ Pediatric Treatment0.659091
statistically significant results0.596562
PDQ Pediatric Cancer0.649154
series experiences0.541012
clinical experiences0.670302
different expert panels0.607615
overall strength0.584647
definable population0.605214
study results0.54495
previously conducted studies0.628589
Cancer Treatment Summaries0.759718
clinical studies0.588362
population-based studies0.62839
subset analyses0.608887
CLICK HERE
1627 National Cancer Institute Html en Liver (Hepatocellular) Cancer Prevention (PDQ®)–Patient Version Hepatitis B and C, cirrhosis, and aflatoxin (poison from certain foods) are important risk factors for liver cancer. Learn about all of the risk factors for liver cancer and how to prevent liver cancer in this expert-reviewed summary.
hepatocellular) cancer:0.61402
cancer risk factors0.453697
Cancer prevention0.626716
cancer prevention trials0.490017
Hepatitis viruses0.484698
hepatitis G virus0.482783
cancer protective factor0.439442
hepatitis B virus0.48738
hepatitis infection0.475638
hepatitis B.0.524229
protective factors0.458515
following PDQ summaries0.446108
Cancer Information Service0.428793
PDQ cancer information0.628691
hepatitis E virus0.48361
prevention clinical trials0.441049
acute hepatitis0.480938
Hepatitis A vaccine0.480499
Prevention Editorial Board0.442759
hepatitis C virus0.486051
National Cancer Institute0.524466
clinical trials0.620519
especially hepatitis0.473486
cancer information summary0.538122
risk factors0.559595
breast cancer prevention0.419616
hepatitis virus0.531251
hepatitis B vaccine0.480451
liver cancer prevention0.489862
Cancer Care page0.416878
PDQ database0.39653
hepatitis C.0.481259
cancer risk factor0.462005
hepatitis0.804007
NCI’s PDQ0.403154
PDQ summary0.417038
hepatitis A virus0.488307
NCI PDQ cancer0.479454
chronic hepatitis0.527021
cancer clinical trials0.440605
hepatitis D virus0.484344
hepatitis B infection0.473174
healthy liver tissue0.433816
cancer information summaries0.436678
comprehensive cancer information0.436454
cancer0.929112
CLICK HERE
1761 National Cancer Institute Html en HIV Infection and Cancer Risk A fact sheet that describes the increased risk of certain types of cancer by people infected with HIV.
HIV-infected persons0.508754
Interagency HIV Study0.502379
lung cancer0.484047
B-cell non-Hodgkin lymphoma0.458276
J. Hepatocellular cancer0.468864
non-HIV cancer risk0.494393
Cancer Specimen Resource0.469635
HIV-infected populations0.478653
AIDS Malignancy0.457277
cervical cancer0.693342
Cancer Match Study0.479104
current HIV treatment0.516027
cause liver cancer0.489672
Shiels MS0.582975
recent cancer trends0.457251
Cancer Epidemiology0.46223
cancers0.670125
human immunodeficiency virus0.500937
HIV-infected population0.54327
HIV-infected people0.947346
United States0.521772
non–AIDS-defining cancers0.549624
antiretroviral therapy0.544479
non-Hodgkin lymphoma0.547712
poorer cancer survival0.482973
general population0.519659
A. HIV infection0.48948
Kaposi sarcoma0.627254
anal cancers0.515539
HIV-associated cancers0.517566
AIDS-defining cancers0.457988
National Cancer Institute0.47979
substantially higher risk0.462943
Silverberg MJ0.555726
Hodgkin lymphoma0.483616
AIDS Cancer Clinical0.500517
higher risk0.566781
HIV-infected individuals0.743448
HIV-related cancers0.456193
anal cancer0.625604
HIV-infected women0.50457
oral cavity/pharynx cancer0.497269
cancer risk0.617858
et al0.549092
New England Journal0.468444
cancer0.93948
liver cancer0.56236
appropriate cancer treatment0.491194
HIV infection0.611339
CLICK HERE
1814 National Cancer Institute Html es Tratamiento del cáncer de esófago (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer de esófago.
potentially operable carcinoma0.227364
Compton CC0.235729
gastric cardia carcinomas0.224835
oesophageal cancer0.276104
M0 TX0.378744
largo plazo0.224774
7th ed0.235623
Oesophageal Cancer Followed0.223828
Symptomatic gastroesophageal reflux0.225069
ecografía endoscópica0.322801
Estados Unidos0.43962
mortalidad perioperatoria0.229531
Natl Cancer Inst0.232717
estadificación tnm0.223626
La incidencia0.230541
estadio iv0.258573
M0 T20.809899
tumor.ampliar cáncer0.321047
M0 T10.972287
Lerut A0.228355
M0 T30.670603
estadio ib0.273395
estadio ia0.270617
células escamosas versus0.290657
Van Cutsem E0.252346
Estadio Grado Localización0.256738
mucosa esofágica distal0.27828
tumor.ampliar adenocarcinoma0.241411
Cancer Staging Manual0.279268
iia 1-x superior0.228
Thorac Cardiovasc Surg0.318859
estadio iiia0.354448
PDQ Tratamiento0.239147
New York0.233171
invasive surgical staging0.223534
estadio iiic0.343305
estadio iia0.319628
Cancer treatment0.223659
Clin Oncol0.262378
medio t2–30.237546
Byrd DR0.234186
M1 TX0.23325
American Joint Committee0.2654
Thorac Surg0.250251
M0 Tis0.325056
positron emission tomography0.377883
Am Coll Surg0.230102
M0 T4a0.550107
AJCC Cancer Staging0.282666
CLICK HERE
1835 National Cancer Institute Html es Tratamiento del mesotelioma maligno (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer del mesiotelioma maligno.
advanced malignant0.116955
Cancer Res Clin0.143881
unresectable malignant mesothelioma0.113438
malignant mesothelioma previously0.112719
Lung Cancer Study0.118498
Leukemia Group0.124194
Venkatraman E0.115582
therapy with induction0.114339
Antman KH0.111559
Vogelzang NJ0.12467
systemic chemotherapy0.119496
patients with mesothelioma0.113972
Thorac Oncol0.117632
malignant mesothelioma0.548307
with induction chemotherapy0.120652
cisplatino versus0.116229
Res Clin Oncol0.141606
mesotelioma sarcomatoide0.113237
intraperitoneal chemotherapy as0.127133
patients with0.17944
Union Against Cancer0.114155
chemotherapy followed0.119996
cisplatin-based intraperitoneal chemotherapy0.127819
Lung Cancer0.119323
multimodality approach0.111112
PDQ Síndromes cardiopulmonares0.116256
pleural maligno difuso0.117211
Rusch VW0.116274
patients with malignant0.151958
National Cancer Institute0.112603
induction chemotherapy followed0.11661
Thorac Cardiovasc Surg0.13604
Trimodality therapy with0.114339
malignant pleural mesothelioma0.977908
malignant peritoneal mesothelioma0.154368
Clin Oncol0.739133
extrapleural pneumonectomy0.187603
diagnosed pleural mesothelioma0.118912
DeCamp M0.110451
pleural mesothelioma using0.118896
cisplatino pemetrexed0.111439
chemotherapy as treatment0.13551
treated patients with0.113408
advanced malignant mesothelioma0.112494
Mentzer SJ0.110243
European Organization0.127591
Thorac Surg0.114739
diffuse malignant mesothelioma0.138575
pleural malignant0.119345
CLICK HERE
1908 National Cancer Institute Html es Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos.
linfocítica aguda0.505572
leucemia promielocítica aguda0.536157
siguientes procedimientos0.505247
células madre0.703397
leucemia mielógena aguda0.512482
posibles factores0.501447
siguientes aspectos0.5019
leucemia aguda0.511873
radiación quizás0.505162
leucemia linfoblástica aguda0.535526
LMA quizás0.505703
hueso compacto0.505434
neoplasias mieloides0.501631
rayos x0.501258
enlace drugs approved0.505977
Acute Myeloid Leukemia0.506164
célula madre mieloide0.516071
cáncer.ampliar aspiración0.501565
líquido cefalorraquídeo0.511938
punción espinal.Ampliar0.501523
National Cancer Institute0.501258
leucemia granulocítica aguda0.512402
Instituto Nacional0.502137
célula madre linfoide0.510737
PDQ Tratamiento0.503456
sustancia química benceno0.502803
leucemia mielógena0.513696
médula espinal.ampliar quimioterapia0.50588
leucemia mieloblástica aguda0.512403
sistema nervioso central0.50789
Physician Data Query0.504454
madre mieloides0.518606
siguientes situaciones0.504197
células madre mieloides0.508803
leucemia mieloide aguda0.995372
célula madre0.532153
blastocito mieloide0.505386
siguientes sumarios0.503116
CLICK HERE
1964 National Cancer Institute Html es Tratamiento del cáncer de uretra (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de uretra.
uretra distal0.983772
siguientes procedimientos0.582434
siguientes elementos0.524145
siguientes aspectos0.522333
proximal.ampliar anatomía0.514787
enfermedad.ampliar ureteroscopía0.522025
Physician Data Query0.500221
VPH tipo0.523805
túbulos renales0.527052
siguientes tipos0.512788
libre uso0.498555
media pulgada0.51317
rayos x0.553518
sistema urinario masculino0.542122
pequeño rulo0.511879
Cancer Institute0.497836
siguientes riesgos0.497881
realidad células0.521213
pelvis renal0.642604
Institutos Nacionales0.50085
CLICK HERE
2987 National Cancer Institute Html en Secondhand Smoke When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly.
feet0.409991
dangers0.420271
Lung cancer0.428942
good example0.428021
non-smoker0.407426
care staff0.426607
nicotine affect0.427281
babysitters0.406286
body0.411562
smoker0.414092
children0.431937
harms0.407652
sure caretakers0.428123
secondhand smoke0.971613
non-smokers0.43912
heart disease‚0.429635
Fact0.410452
short time0.429909
somebody0.406088
health problems0.428728
smokefree restaurants0.432863
lung infections0.428228
smoking indoors0.445671
main way smoking0.477206
Breathing problems0.428866
indoor public places0.450365
babies0.424287
smokers0.419121
air0.417572
life0.412446
Breathing secondhand smoke0.5983
infant death syndrome0.453829
smoking0.508887
National Cancer Institute0.448359
heart attack‚0.429618
kids0.411336
quiz0.411311
cigarette0.405834
coughing‚ extra phlegm‚0.454984
bronchitis0.405901
people0.432125
home0.416331
nannies0.405803
severe attacks0.428972
best thing0.428251
shortness0.406847
ear infections0.428442
low birth weight0.454001
family0.425482
CLICK HERE
16650 National Cancer Institute Html en IOTF Mentors: Track 1 and Track 2 While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 1 and 2.
drug product review0.763531
Clinical Evaluation0.730644
Advisory Committee meetings0.730511
Hematology Oncology Toxicology0.80093
Oncology Drug Regulation0.827479
FDA Office0.747931
FDA scientific review0.854344
pharmaceutical manufacturers0.733082
Oncology Products Office0.814936
research0.757558
Biologics Evaluation0.740263
clinical pharmacologists0.727898
Regulatory training0.800464
investigational new drugs0.747261
Clinical Oncology Reviewer0.848942
continued clinical activities0.77796
clinical trials0.899868
trial design0.727681
Attend professional meetings0.742121
multiple datasets/clinical trials0.738642
Investigational New Drug0.775585
single clinical trial0.788427
new drug applications0.86424
clinical outcome0.778656
NDA review process0.758002
clinical pharmacology0.838285
oncologic product development0.729454
Innovative clinical trial0.816069
internal FDA meetings0.79892
FDA0.887939
Biologic License Applications0.733421
clinical oncologists0.919688
Innovative Quantitative Methods0.737333
new drugs0.799324
Drug Evaluation0.758545
new computational methods0.750069
Pivotal Trial Data0.777331
NIH clinical center0.785514
phase clinical oncology0.913342
clinical oncology trials0.923
oncology products0.879348
oncology product development0.777566
clinical trials design0.798466
late phase trials0.755358
gene therapies0.850877
clinical trial data0.865175
Oncology Drug Products0.81665
data analysis methods0.780168
research project0.749995
CLICK HERE
16867 National Cancer Institute Html null Cómo encontrar a un doctor o un establecimiento de tratamiento si usted tiene cáncer Hoja informativa que ofrece sugerencias para escoger a un médico y un establecimiento para el tratamiento del cáncer.
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.